ATH-05

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameATH-05

Drug Alias NamePCSK9 peptide vaccine (AFFiRiS)proprotein convertase PC9 vaccine (AFFiRiS)ATH-05

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionLDL receptor modulatorsProprotein convertase subtilisin kexin type 9 inhibitors

TargetsProprotein convertase subtilisin kexin type 9LDL receptor

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAffiris Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAffiris Ag

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A